C11orf24: A Drug Target / Disease Biomarker (G53838)

Target Name: C11orf24

NCBI ID: G53838

C11orf24

C11orf24: A Drug Target / Disease Biomarker

C11orf24 is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its name is derived from the words C11, which represents the 11th chromosome, and orf24, which is a gene that encodes a protein known as ORF24.

C11orf24 is a non-coding RNA molecule that is expressed in many different tissues and cells in the body. It is primarily expressed in the brain, where it is found at high levels in the prefrontal cortex, a region of the brain that is responsible for various higher-order cognitive functions.

Several studies have suggested that C11orf24 may play a role in the development and progression of various neurological and psychiatric disorders. For example, researchers have found that individuals with certain genetic variations in the C11orf24 gene are at increased risk for developing schizophrenia and other psychotic disorders.

In addition, C11orf24 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have shown that individuals with certain genetic variations in the C11orf24 gene are at increased risk for developing these conditions.

Furthermore, C11orf24 has also been suggested as a potential biomarker for various autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. Studies have shown that individuals with certain genetic variations in the C11orf24 gene are more likely to develop these conditions, and that targeting the C11orf24 gene may be a promising approach for treating these disorders.

Despite the potential implications of C11orf24 as a drug target or biomarker, more research is needed to fully understand its role in the development and progression of various neurological and psychiatric disorders. Researchers are currently studying the C11orf24 gene to gain a better understanding of its function and to identify potential drug targets or biomarkers.

In conclusion, C11orf24 is a gene that has the potential to be a drug target or biomarker for various neurological and psychiatric disorders. Its expression and involvement in the development and progression of these conditions make it an attractive target for future research and potential treatment. Further studies are needed to fully understand its function and to identify potential drug targets or biomarkers.

Protein Name: Chromosome 11 Open Reading Frame 24

The "C11orf24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C11orf24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets